NSE: FORTIS | BSE: 532843

Download real time

786.25 23.25 (3.05%)

28.80% Fall from 52W High

3.8M NSE+BSE Volume

NSE 09 Oct, 2026 3:31 PM (IST)

59,358.6

Market Cap

High in industry

Beta 1Year

Very Low volatility

Regulatory Tailwind

Fortis rises on Friday as Centre caps trade margins on cancer drugs at 30%, above SC's 16% proposal See details

Fortis Healthcare Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for FORTIS, BSE:532843 Fortis Healthcare Ltd.

Search Inside the pdf :

Fortis Healthcare Ltd.

06 Sep 2026

786.25

3.05%

Forensic audit likely to be an overhang on price, but neutral to operations

Buy: Fortis Healthcare Ltd.

ICICI Securities Limited

In litigation ongoing since 2018, the Delhi High Court on 31st Aug’26, accepted Daiichi’s demand for a forensic audit. S Ramanand Aiyar & Co will conduct the audit and examine all Fortis share and fund movements since 24 May’16, including the scrutiny of INR 46.66bn transferred to RHT (Religare Health Trust) and the Fortis-IHH-RHT Health transaction chain.

Fortis Healthcare has lost -26.44% in the last 1 Year

Fortis Healthcare Ltd.

04 Sep 2026

786.25

3.05%

High Court orders forensic audit; operational aspects remain intact

Buy: Fortis Healthcare Ltd.

Target

Motilal Oswal

The Delhi High Court has directed the appointment of a forensic auditor to examine certain historical transactions involving Fortis Healthcare (FORH), including the dissipation of the erstwhile promoters’ stake.

Number of FII/FPI investors decreased from 735 to 727 in Jun 2026 qtr

Fortis Healthcare Ltd.

09 Aug 2026, 12:00AM

786.25

3.05%

Brownfield expansion set to improve operating metrics

Buy: Fortis Healthcare Ltd.

Recommendation Target

ICICI Securities Limited

Fortis Healthcare’s (Fortis) delivered a healthy Q1FY27 result with operating performance broadly in line with our expectations. However, ESOP costs (INR 310mn) and overheads (impact of 50-60bps) at new hospitals dragged hospital margins (down 200bps YoY).

Fortis Healthcare has lost -26.44% in the last 1 Year

Fortis Healthcare Ltd.

15 Jun 2026

786.25

3.05%

FORTIS HEALTHCARE LIMITED

Buy: Fortis Healthcare Ltd.

Target

Geojit BNP Paribas

*over or under performance to benchmark index Diagnostics business gross revenue rose 11.1% YoY to Rs. 387cr, driven by portfolio expansion, improving customer touchpoints and sustained traction across preventive and core testing segments. EBITDA increased 22.2% YoY to Rs. 532cr, while EBITDA margin expanded 80bps to 22.5%, driven by operating leverage, better hospital profitability and continued improvement in diagnostic business execution...

Fortis Healthcare has lost -26.44% in the last 1 Year

Fortis Healthcare Ltd.

28 Feb 2026

786.25

3.05%

Pick of the Week:Fortis Health.

Buy: Fortis Healthcare Ltd.

Target

Axis Direct

We recommend a BUY with a target price of Rs 1,038, implying an upside of ~10% from the CMP.

Fortis Healthcare has lost -26.44% in the last 1 Year

Fortis Healthcare Ltd.

17 Feb 2026

786.25

3.05%

Result Update:Fortis Health.

Buy: Fortis Healthcare Ltd.

Axis Direct

We maintain a BUY rating on Fortis Healthcare with a target price of Rs 1,070/share

Fortis Healthcare Ltd. is trading below all available SMAs

Fortis Healthcare Ltd.

17 Feb 2026

786.25

3.05%

Fortis Healthcare (FORH IN) Q3FY26 Result Update Strong growth across segments BUY

Buy: Fortis Healthcare Ltd.

Target

Prabhudas Lilladhar

Fortis Healthcare (FORH) reported another strong quarter with EBITDA of Rs5.1bn in Q3FY26, up 35% YoY. Though hospital margin has improved by 550bps bps YoY over FY23-9MFY26 to 23%, we see further scope for improvement aided by 1) improving case and payor mix, 2) cost rationalization initiatives and ramp-up of Manesar and Greater Noida unit, and 3) new brownfield bed additions. Additionally, we expect margin to expand further,...

Fortis Healthcare Ltd. is trading below all available SMAs

Fortis Healthcare Ltd.

22 Dec 2025

786.25

3.05%

FORTIS HEALTHCARE LIMITED

Buy: Fortis Healthcare Ltd.

Recommendation Target

Geojit BNP Paribas

400-500 beds, supported by capacity expansion in Noida and Jalandhar. Fortis is targeting an EBITDA margin of 25% in the hospital business for the next couple of years. Additionally, the international patients segment is...

Number of FII/FPI investors decreased from 735 to 727 in Jun 2026 qtr

Fortis Healthcare Ltd.

13 Nov 2025

786.25

3.05%

Robust execution and network expansion to support growth

Hold: Fortis Healthcare Ltd.

Recommendation Target

ICICI Securities Limited

Fortis Healthcare (Fortis) delivered a strong beat in EBITDA and PAT led by stronger margins across its hospitals (+140bps) and diagnostic verticals (+510bps).